Hypertension quadpill cost effective: Study A four-in-one high blood pressure pill would be an impactful and cost-effective addition to the Australian market, according to research.
RACGP tours WA to discuss doctor shortage Boosting access to remote medical treatment was the top priority of an RACGP leaders tour of Western Australia.
GlucaGen Hypokit in short supply until October Another diabetes medication is now facing supply issues, adding to worldwide shortages of semaglutide and dulaglutide.
New advice for ‘unprecedented’ antibiotics shortage With ongoing supply issues, Therapeutic Guidelines has released a guide for prescribers on alternatives in the absence of first-line therapies.
Almost all blood pressure medications reduce migraine: Study The drugs could be used much more widely as an inexpensive preventive measure, new research suggests.
Does multimorbidity impact chronic disease treatment? New international research has looked into a range of chronic diseases and their potential impact on effectiveness of common medications.
RACGP moves to shore up wavering support for 60-day dispensing Amid reports of crossbenchers becoming wary of the reform, the college has co-signed an open letter outlining the expected benefits for both patients and the primary care system.
How to help patients save when prescribing expensive medication SPONSORED: Depending on their health fund and level of cover, they may have benefits that cover medication not eligible for a government subsidy.
Around 50% of pharmacists intend to quit by 2033: Study And with pharmacy already experiencing workforce shortages, the RACGP Vice President is concerned expanding their scope of practice will make matters worse.
In Practice: Managing tick-borne illnesses The information is aimed to further support health professionals and patients to better understand tick-borne illness in Australia.